Long-term survival in a patient with chronic myelogenous leukemia without any treatment

Loading...
Thumbnail Image

Journal Title

Journal ISSN

Volume Title

Publisher

Brieflands

Abstract

Chronic myelogenous leukemia (CML) is a myeloproliferative disease with a well known course. With chemotherapy,   average survival of these  patients is   3-5 years. All of the   long term survivors  of CML   have been  treated patients. Here we are reporting on a  long term survivor (more than 10 years)  without treatment.

Description

Keywords

Citation

URI

Endorsement

Review

Supplemented By

Referenced By